Dual Effect of DLBCL-derived EXOs in Lymphoma to Improve DC Vaccine Efficacy in Vitro While Favor Tumorgenesis in Vivo

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-0863-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Correction to Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2018English

In Vitro and in Vivo Efficacy of a Rift Valley Fever Virus Vaccine Based on Pseudovirus

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Exploiting Dendritic Cells to Improve Vaccine Efficacy

Journal of Clinical Investigation
Medicine
2002English

ABT-263 and Rapamycin Act Cooperatively to Kill Lymphoma Cells in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

A Super TLR Agonist to Improve Efficacy of Dendritic Cell Vaccine in Induction of Anti-HCV Immunity

PLoS ONE
Multidisciplinary
2012English

In Vivo Rho GTPase-Activating Protein Activity of Pseudomonas Aeruginosa Cytotoxin ExoS

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2002English

Prediction Method of DC Bias in DC-DC Dual-Active-Bridge Converter

CPSS Transactions on Power Electronics and Applications
2019English

Can Follicular Helper T Cells Be Targeted to Improve Vaccine Efficacy?

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Obatoclax Interacts Synergistically With the Irreversible Proteasome Inhibitor Carfilzomib in GC- And ABC-DLBCL Cells in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy